Small Molecule Drugs, Gene Regulation Therapies-Innate Immunity & Pyroptosis Modulators
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
101
NCT03201835
5-Way Crossover Study to Compare the Safety, Tolerability and Pharmacokinetics of New Oral Cannabinoid Formulations Administered as Single Doses, With Buccal Sativex®, in Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 24, 2015
Completion: Jun 6, 2016
NCT02987114
A Study to Evaluate the Safety, Tolerability and Efficacy of Oral Administration of PTL101 (Cannabidiol) as an Adjunctive Treatment for Pediatric Intractable Epilepsy
Phase: Phase 2
Start: Feb 13, 2017
Completion: Jun 28, 2018
NCT03005119
Evaluation of the Safety, Tolerability, and Efficacy of Orally Administered PTL201 in MS Patients With Spasticity-related Symptoms
Start: Mar 1, 2018
Completion: Dec 31, 2018
Loading map...